Careers  |  Sign In  |  Register  |   Twitter

Latest in Pharmacists

According to Reuters, Ibrance, a breast cancer drug from Pfizer is currently in Phase III clinical trials of a new drug. The drug is designed to treat the most common type of breast cancer, estrogen-receptor positive, human epidermal growth factor receptor 2-negative. Ibrance has been shown to increase the...
According to Reuters, the FDA has recently approved a drug by Pfizer to treat a rare lung disease most frequently found in women of childbearing age. The disease known as lymphangioleiomyomatosis (LAM) typically presents with symptoms similar to that of other lung conditions like emphysema or asthma but...
Patients struggling with addictions to prescription drugs and heroin often seek care in hospital emergency departments. However, the primary option available for emergency department staff is referral to addiction treatment services. A new study evaluated whether these patients would be more successful in...